Matsumoto M - Search Results

1

Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group.

Kobayashi T, Tobinai K, Shimoyama M, Mikuni C, Konda S, Kozuru M, Araki K, Sai T, Fukuhara S, Matsumoto M, Aoki I, Deura K, Oyama A, Hotta T, Abe T, Toki H, Nagai M, Fukuda H, Niimi M, Yamaguchi N, Tajima K, Shirakawa S. Kobayashi T, et al. Among authors: matsumoto m. Jpn J Clin Oncol. 1999 Jul;29(7):340-8. doi: 10.1093/jjco/29.7.340. Jpn J Clin Oncol. 1999. PMID: 10470659 Clinical Trial.

2

Deficiency of complement decay-accelerating factor (DAF, CD55) in non-Hodgkin's lymphoma.

Fukuda H, Seya T, Hara T, Matsumoto M, Kinoshita T, Masaoka T. Fukuda H, et al. Among authors: matsumoto m. Immunol Lett. 1991 Aug;29(3):205-9. doi: 10.1016/0165-2478(91)90171-6. Immunol Lett. 1991. PMID: 1722775

3

Pseudophakic cystoid macular edema treated with high-dose intravenous methylprednisolone.

Abe T, Hayasaka S, Nagaki Y, Kadoi C, Matsumoto M, Hayasaka Y. Abe T, et al. Among authors: matsumoto m. J Cataract Refract Surg. 1999 Sep;25(9):1286-8. doi: 10.1016/s0886-3350(99)00159-5. J Cataract Refract Surg. 1999. PMID: 10476516

4

Development of an ELISA assay for soluble CD35 (C3b/C4b receptor): high levels of soluble CD35 in LE-positive patients with hematological malignancies.

Hara T, Fukuda H, Masaoka T, Matsumoto M, Seya T. Hara T, et al. Among authors: matsumoto m. Immunol Lett. 1994 Jul;41(2-3):249-53. doi: 10.1016/0165-2478(94)90141-4. Immunol Lett. 1994. PMID: 8002046

5

Superoxide dismutase in psoriasis, squamous cell carcinoma and basal cell epithelioma: an immunohistochemical study.

Kobayashi T, Matsumoto M, Iizuka H, Suzuki K, Taniguchi N. Kobayashi T, et al. Among authors: matsumoto m. Br J Dermatol. 1991 Jun;124(6):555-9. doi: 10.1111/j.1365-2133.1991.tb04950.x. Br J Dermatol. 1991. PMID: 2064938

6

Acute promyelocytic leukemia with CD59 deficiency.

Seya T, Tejima H, Fukuda H, Hara T, Matsumoto M, Hatanaka M, Sugita Y, Masaoka T. Seya T, et al. Among authors: matsumoto m. Leuk Res. 1993 Oct;17(10):895-6. doi: 10.1016/0145-2126(93)90155-e. Leuk Res. 1993. PMID: 7692187

7

Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation.

Tsuboi K, Kishi K, Ohmachi K, Yasuda Y, Shimizu T, Inoue H, Matsumoto M, Hattori K, Yoshiba F, Watanabe S, Ogawa Y, Kawada H, Yabe H, Yabe M, Kato S, Hotta T. Tsuboi K, et al. Among authors: matsumoto m. Bone Marrow Transplant. 2003 Nov;32(9):903-7. doi: 10.1038/sj.bmt.1704240. Bone Marrow Transplant. 2003. PMID: 14561991

8

Angiomyofibroblastoma of the vulva: report of a case.

Tochika N, Takeshita A, Sonobe H, Matsumoto M, Kobayashi M, Araki K. Tochika N, et al. Among authors: matsumoto m. Surg Today. 2001;31(6):557-9. doi: 10.1007/s005950170123. Surg Today. 2001. PMID: 11428615 Review.

9

Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies.

Hara T, Kojima A, Fukuda H, Masaoka T, Fukumori Y, Matsumoto M, Seya T. Hara T, et al. Among authors: matsumoto m. Br J Haematol. 1992 Oct;82(2):368-73. doi: 10.1111/j.1365-2141.1992.tb06431.x. Br J Haematol. 1992. PMID: 1384649

10

T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties.

Takatsu K, Tominaga A, Harada N, Mita S, Matsumoto M, Takahashi T, Kikuchi Y, Yamaguchi N. Takatsu K, et al. Among authors: matsumoto m. Immunol Rev. 1988 Feb;102:107-35. doi: 10.1111/j.1600-065x.1988.tb00743.x. Immunol Rev. 1988. PMID: 3284812 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,846 results

Search Page

Filters